G.Barekat Pharm (XTEH:BRKT1) ROCE % : 49.53% (As of Mar. 2017)

View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. G.Barekat Pharm's annualized ROCE % for the quarter that ended in Mar. 2017 was 49.53%.

G.Barekat Pharm ROCE % Historical Data

The historical data trend for G.Barekat Pharm's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm ROCE % Chart

G.Barekat Pharm Annual Data

Trend

Mar16

Mar17

ROCE %

49.53

G.Barekat Pharm Semi-Annual Data
	Mar16	Mar17
ROCE %	-	49.53

G.Barekat Pharm ROCE % Calculation

G.Barekat Pharm's annualized ROCE % for the fiscal year that ended in Mar. 2017 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2017 )		(A: Mar. 2016 )		(A: Mar. 2017 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2017 )		(A: Mar. 2016 )		(A: Mar. 2017 )
	=	5465455	/	( ( (0 - 0)	+	(34818314 - 23783434) )	/ 1 )
	=	5465455	/	( (0	+	11034880)	/ 1 )
	=	5465455	/	11034880
	=	49.53 %

G.Barekat Pharm's ROCE % of for the quarter that ended in Mar. 2017 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2017 )		(Q: Mar. 2016 )		(Q: Mar. 2017 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2017 )		(Q: Mar. 2016 )		(Q: Mar. 2017 )
	=	5465455	/	( ( (0 - 0)	+	(34818314 - 23783434) )	/ 1 )
	=	5465455	/	( ( 0	+	11034880 )	/ 1 )
	=	5465455	/	11034880
	=	49.53 %

(1) Note: The EBIT data used here is one times the annual (Mar. 2017) EBIT data.

G.Barekat Pharm (XTEH:BRKT1) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

G.Barekat Pharm ROCE % Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN

Website

http://www.bpharmed.com

G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines